首页> 外文OA文献 >Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women

【2h】

Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women

机译：Relugolix，一种新型口服促性腺激素 - 释放激素拮抗剂，治疗与子宫肌瘤相关的疼痛症状：日本女性随机，安慰剂控制，第3期第3期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yutaka Osuga; Kazuaki Enya; Kentarou Kudou; Hiroshi Hoshiai;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women [J] . Osuga Yutaka, Enya Kazuaki, Kudou Kentarou, Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society . 2019,第5期

机译：Relugolix，一种新型口服促性腺激素 - 释放激素拮抗剂，治疗与子宫肌瘤相关的疼痛症状：日本女性的随机，安慰剂控制，第3期第3期研究
2. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas A Randomized Controlled Trial [J] . Osuga Yutaka, Enya Kazuaki, Kudou Kentarou, Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists . 2019,第3期

机译：口服促性腺激素 - 释放激素拮抗剂Relugolix与子宫水蛭素注射的血清蛋白酶对随机对照试验进行比较
3. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial [J] . Yutaka Osuga, Kazuaki Enya, Kentarou Kudou, Obstetrical and gynecological survey . 2019,第7期

机译：口服促性腺激素 - 释放激素拮抗剂Relugolix与子宫水蛭瘤的Leuprorelin注射蛋白酶：随机对照试验
4. Type A Botulinum Toxin in the treatment of bruxism clenching and facial pain: randomized blinded placebo-controlled study [C] . Tonello S., Ferronato G., Guarda-Nardini L. Societaà Italiana Chirurgia Maxillo-Facciale . 2011

机译：在治疗乳白质咬合和面部疼痛的治疗中键入肉毒杆菌毒素：随机盲目安慰剂对照研究
5. Combined Oral Contraceptive Utilization and Uterine Fibroid Incidence and Prevalence in The Study of Environment, Lifestyle, and Fibroids (SELF) [D] . Hoffman, Sarah Ruth. 2019

机译：组合口服避孕药和子宫肌瘤发生率和患有环境，生活方式和肌瘤（自我）的研究
6. Ulipristal acetate for Japanese women with symptomatic uterine fibroids: A double‐blind randomized phase II dose‐finding study [O] . Minoru Irahara, Yasuhiro Maejima, Nobuhiro Shinbo, 2020

机译：适用于日本女性有症状子宫肌瘤的醋酸尿上皮：一项双盲随机II期剂量寻找研究
7. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study [O] . Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, 2021

机译：Relugolix是一种口服促性腺激素释放激素受体拮抗剂，以剂量反应方式减少子宫内膜异位症相关的疼痛：随机，双盲，安慰剂对照研究

Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women

著录项

相似文献

相关主题

期刊订阅